Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins(University of Oxford), Richard Peto(University of Oxford), Anthony Rodgers(The George Institute for Global Health), Salim Yusuf(Population Health Research Institute), Liam Smeeth(London School of Hygiene & Tropical Medicine), Jane Armitage, Stephen MacMahon, Peter Sandercock(University College London), Colin Baigent(University of Oxford), Jonathan Emberson(University of Oxford), John Danesh(University of Cambridge), David Preiss(Medical Research Council), Ian Roberts(University of London), Nicholas Wald(University College London), David L. DeMets(University of Wisconsin–Madison), Kenneth F. Schulz(University of North Carolina at Chapel Hill), Stephen Evans(London School of Hygiene & Tropical Medicine), Lisa Blackwell(University of Oxford), Christina Reith(University of Oxford), Neil R Poulter(Imperial College London), Bruce Neal(UNSW Sydney), John Simes(The University of Sydney), Roger S. Blumenthal(House of Representatives), Paul M. Ridker(Herlev Hospital), George Davey Smith(University of Bristol), Peter Sever(Imperial College London), Seth S. Martin(Johns Hopkins University)
Cited by 1,841
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k